Lymphoma, B-Cell

Name
Lymphoma, B-Cell
Accession Number
DBCAT000176
Description

Not Available

Drugs
DrugDrug Description
Ibritumomab tiuxetanA monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.
TafasitamabA CD19-directed cytolytic monoclonal antibody used in the treatment of B-cell malignancies.
Drugs & Drug Targets
DrugTargetType
Ibritumomab tiuxetanB-lymphocyte antigen CD20target
TafasitamabB-lymphocyte antigen CD19target